Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.

Identifieur interne : 003300 ( PubMed/Curation ); précédent : 003299; suivant : 003301

Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.

Auteurs : Xavier Castellsagué [Espagne] ; Jorma Paavonen [Finlande] ; Unnop Jaisamrarn [Thaïlande] ; Cosette M. Wheeler [États-Unis] ; S Rachel Skinner [Australie] ; Matti Lehtinen [Finlande] ; Paulo Naud [Brésil] ; Song-Nan Chow [Taïwan] ; Maria Rowena Del Rosario-Raymundo [Philippines] ; Julio C. Teixeira [Brésil] ; Johanna Palmroth [Finlande] ; Newton S. De Carvalho [Brésil] ; Maria Julieta V. Germar [Philippines] ; Klaus Peters [Allemagne] ; Suzanne M. Garland [Australie] ; Anne Szarewski [Royaume-Uni] ; Willy A J. Poppe [Belgique] ; Barbara Romanowski [Canada] ; Tino F. Schwarz [Allemagne] ; Wiebren A A. Tjalma [Belgique] ; F Xavier Bosch [Espagne] ; Marie-Cecile Bozonnat [France] ; Frank Struyf [Belgique] ; Gary Dubin [États-Unis] ; Dominique Rosillon [Belgique] ; Laurence Baril [Belgique]

Source :

RBID : pubmed:25927224

Descripteurs français

English descriptors

Abstract

More information is needed about time between sexual initiation and human papillomavirus (HPV) infection and development of cervical precancer.

DOI: 10.1186/s12879-014-0551-y
PubMed: 25927224

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:25927224

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.</title>
<author>
<name sortKey="Castellsague, Xavier" sort="Castellsague, Xavier" uniqKey="Castellsague X" first="Xavier" last="Castellsagué">Xavier Castellsagué</name>
<affiliation wicri:level="1">
<nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, CIBER-ESP, L'Hospitalet de Llobregat, Avda. Gran via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. xcastellsague@iconcologia.net.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, CIBER-ESP, L'Hospitalet de Llobregat, Avda. Gran via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Paavonen, Jorma" sort="Paavonen, Jorma" uniqKey="Paavonen J" first="Jorma" last="Paavonen">Jorma Paavonen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynaecology, University of Helsinki, Helsinki, Finland. Jorma.Paavonen@hus.fi.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Department of Obstetrics and Gynaecology, University of Helsinki, Helsinki</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Jaisamrarn, Unnop" sort="Jaisamrarn, Unnop" uniqKey="Jaisamrarn U" first="Unnop" last="Jaisamrarn">Unnop Jaisamrarn</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynaecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. dr.unnop@yahoo.com.</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Department of Obstetrics and Gynaecology, Faculty of Medicine, Chulalongkorn University, Bangkok</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wheeler, Cosette M" sort="Wheeler, Cosette M" uniqKey="Wheeler C" first="Cosette M" last="Wheeler">Cosette M. Wheeler</name>
<affiliation wicri:level="1">
<nlm:affiliation>Departments of Pathology and Obstetrics and Gynecology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA. CWheeler@salud.unm.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Pathology and Obstetrics and Gynecology, University of New Mexico Health Sciences Center, Albuquerque, NM</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Skinner, S Rachel" sort="Skinner, S Rachel" uniqKey="Skinner S" first="S Rachel" last="Skinner">S Rachel Skinner</name>
<affiliation wicri:level="1">
<nlm:affiliation>Vaccines Trials Group, Telethon Institute for Child Health Research, Perth, WA and Sydney University Discipline of Paediatrics and Child Health, Children's Hospital Westmead, Sydney, NSW, Australia. rachels5@chw.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Vaccines Trials Group, Telethon Institute for Child Health Research, Perth, WA and Sydney University Discipline of Paediatrics and Child Health, Children's Hospital Westmead, Sydney, NSW</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lehtinen, Matti" sort="Lehtinen, Matti" uniqKey="Lehtinen M" first="Matti" last="Lehtinen">Matti Lehtinen</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Tampere, School of Public Health, Tampere, Finland. matti.lehtinen@uta.fi.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>University of Tampere, School of Public Health, Tampere</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Naud, Paulo" sort="Naud, Paulo" uniqKey="Naud P" first="Paulo" last="Naud">Paulo Naud</name>
<affiliation wicri:level="1">
<nlm:affiliation>Hospital de Clínicas de Porto Alegre, Department of Gynecology & Obstetrics Federal University of Rio Grande do Sul - UFRGS/HCPA, Porto Alegre, Brazil. cacontrol@hcpa.ufrgs.br.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Hospital de Clínicas de Porto Alegre, Department of Gynecology & Obstetrics Federal University of Rio Grande do Sul - UFRGS/HCPA, Porto Alegre</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Chow, Song Nan" sort="Chow, Song Nan" uniqKey="Chow S" first="Song-Nan" last="Chow">Song-Nan Chow</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, College of Medicine and the Hospital, National Taiwan University, Taipei, Taiwan. snchow@ntu.edu.tw.</nlm:affiliation>
<country xml:lang="fr">Taïwan</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, College of Medicine and the Hospital, National Taiwan University, Taipei</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Del Rosario Raymundo, Maria Rowena" sort="Del Rosario Raymundo, Maria Rowena" uniqKey="Del Rosario Raymundo M" first="Maria Rowena" last="Del Rosario-Raymundo">Maria Rowena Del Rosario-Raymundo</name>
<affiliation wicri:level="1">
<nlm:affiliation>San Pablo Colleges Medical Center, San Pablo City, Laguna, Philippines. runnymeadow@yahoo.com.</nlm:affiliation>
<country xml:lang="fr">Philippines</country>
<wicri:regionArea>San Pablo Colleges Medical Center, San Pablo City, Laguna</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Teixeira, Julio C" sort="Teixeira, Julio C" uniqKey="Teixeira J" first="Julio C" last="Teixeira">Julio C. Teixeira</name>
<affiliation wicri:level="1">
<nlm:affiliation>Departamento de Tocoginecologia da Unicamp, University of Campinas, Campinas, Sao Paulo, Brazil. juliotex@uol.com.br.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Departamento de Tocoginecologia da Unicamp, University of Campinas, Campinas, Sao Paulo</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Palmroth, Johanna" sort="Palmroth, Johanna" uniqKey="Palmroth J" first="Johanna" last="Palmroth">Johanna Palmroth</name>
<affiliation wicri:level="1">
<nlm:affiliation>Central Hospital of North Carelian, Department of Obstetrics and Gynecology, Joensuu, Finland. johanna.palmroth@dnainternet.net.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Central Hospital of North Carelian, Department of Obstetrics and Gynecology, Joensuu</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="De Carvalho, Newton S" sort="De Carvalho, Newton S" uniqKey="De Carvalho N" first="Newton S" last="De Carvalho">Newton S. De Carvalho</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Gynecology and Obstetrics, Federal University of Paraná, Infectious Diseases in Gynecology and Obstetrics Sector, Curitiba, Parana, Brazil. infectogin@ufpr.br.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Gynecology and Obstetrics, Federal University of Paraná, Infectious Diseases in Gynecology and Obstetrics Sector, Curitiba, Parana</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Germar, Maria Julieta V" sort="Germar, Maria Julieta V" uniqKey="Germar M" first="Maria Julieta V" last="Germar">Maria Julieta V. Germar</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynaecology, University of the Philippines College of Medicine, Philippines General Hospital, Manila, Philippines. jvgermar@yahoo.com.</nlm:affiliation>
<country xml:lang="fr">Philippines</country>
<wicri:regionArea>Department of Obstetrics and Gynaecology, University of the Philippines College of Medicine, Philippines General Hospital, Manila</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Peters, Klaus" sort="Peters, Klaus" uniqKey="Peters K" first="Klaus" last="Peters">Klaus Peters</name>
<affiliation wicri:level="1">
<nlm:affiliation>Facharzt für Frauenheilkunde und Geburtshilfe, Hamburg, Germany. klaus@dr-peters.net.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Facharzt für Frauenheilkunde und Geburtshilfe, Hamburg</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Garland, Suzanne M" sort="Garland, Suzanne M" uniqKey="Garland S" first="Suzanne M" last="Garland">Suzanne M. Garland</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville/Department of Microbiology, The Royal Children's Hospital, Parkville/Murdoch Children's Research Institute, Parkville/Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Australia. suzanne.garland@thewomens.org.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville/Department of Microbiology, The Royal Children's Hospital, Parkville/Murdoch Children's Research Institute, Parkville/Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Szarewski, Anne" sort="Szarewski, Anne" uniqKey="Szarewski A" first="Anne" last="Szarewski">Anne Szarewski</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Poppe, Willy A J" sort="Poppe, Willy A J" uniqKey="Poppe W" first="Willy A J" last="Poppe">Willy A J. Poppe</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Gynaecology, University Hospital KU Leuven Gasthuisberg, Leuven, Belgium. willy.Poppe@uz.kuleuven.ac.be.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Gynaecology, University Hospital KU Leuven Gasthuisberg, Leuven</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Romanowski, Barbara" sort="Romanowski, Barbara" uniqKey="Romanowski B" first="Barbara" last="Romanowski">Barbara Romanowski</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. broman@docromanowski.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Schwarz, Tino F" sort="Schwarz, Tino F" uniqKey="Schwarz T" first="Tino F" last="Schwarz">Tino F. Schwarz</name>
<affiliation wicri:level="1">
<nlm:affiliation>Central Laboratory and Vaccination Centre, Stiftung Juliusspital, Academic Teaching Hospital of the University of Wuerzburg, Wuerzburg, Germany. t.schwarz@juliusspital.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Central Laboratory and Vaccination Centre, Stiftung Juliusspital, Academic Teaching Hospital of the University of Wuerzburg, Wuerzburg</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Tjalma, Wiebren A A" sort="Tjalma, Wiebren A A" uniqKey="Tjalma W" first="Wiebren A A" last="Tjalma">Wiebren A A. Tjalma</name>
<affiliation wicri:level="1">
<nlm:affiliation>Multidisciplinary Breast Clinic and Gynaecological Oncology, Antwerp University Hospital, University of Antwerp, Antwerpen, Belgium. wiebren.tjalma@uza.be.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Multidisciplinary Breast Clinic and Gynaecological Oncology, Antwerp University Hospital, University of Antwerp, Antwerpen</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bosch, F Xavier" sort="Bosch, F Xavier" uniqKey="Bosch F" first="F Xavier" last="Bosch">F Xavier Bosch</name>
<affiliation wicri:level="1">
<nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, CIBER-ESP, L'Hospitalet de Llobregat, Avda. Gran via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. x.bosch@iconcologia.net.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, CIBER-ESP, L'Hospitalet de Llobregat, Avda. Gran via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bozonnat, Marie Cecile" sort="Bozonnat, Marie Cecile" uniqKey="Bozonnat M" first="Marie-Cecile" last="Bozonnat">Marie-Cecile Bozonnat</name>
<affiliation wicri:level="1">
<nlm:affiliation>4Clinics, Paris, France. mcbozonnat@4clinics.com.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>4Clinics, Paris</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Struyf, Frank" sort="Struyf, Frank" uniqKey="Struyf F" first="Frank" last="Struyf">Frank Struyf</name>
<affiliation wicri:level="1">
<nlm:affiliation>GlaxoSmithKline Vaccines, Wavre, Belgium. FRANK.STRUYF@GSK.COM.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>GlaxoSmithKline Vaccines, Wavre</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Dubin, Gary" sort="Dubin, Gary" uniqKey="Dubin G" first="Gary" last="Dubin">Gary Dubin</name>
<affiliation wicri:level="1">
<nlm:affiliation>GlaxoSmithKline Vaccines, King of Prussia, PA, USA. Gary.O.Dubin@gsk.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>GlaxoSmithKline Vaccines, King of Prussia, PA</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Rosillon, Dominique" sort="Rosillon, Dominique" uniqKey="Rosillon D" first="Dominique" last="Rosillon">Dominique Rosillon</name>
<affiliation wicri:level="1">
<nlm:affiliation>GlaxoSmithKline Vaccines, Wavre, Belgium. DOMINIQUE.X.ROSILLON@GSK.COM.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>GlaxoSmithKline Vaccines, Wavre</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Baril, Laurence" sort="Baril, Laurence" uniqKey="Baril L" first="Laurence" last="Baril">Laurence Baril</name>
<affiliation wicri:level="1">
<nlm:affiliation>GlaxoSmithKline Vaccines, Wavre, Belgium. LAURENCE.X.BARIL@GSK.COM.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>GlaxoSmithKline Vaccines, Wavre</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25927224</idno>
<idno type="pmid">25927224</idno>
<idno type="doi">10.1186/s12879-014-0551-y</idno>
<idno type="wicri:Area/PubMed/Corpus">003412</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003412</idno>
<idno type="wicri:Area/PubMed/Curation">003300</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003300</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.</title>
<author>
<name sortKey="Castellsague, Xavier" sort="Castellsague, Xavier" uniqKey="Castellsague X" first="Xavier" last="Castellsagué">Xavier Castellsagué</name>
<affiliation wicri:level="1">
<nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, CIBER-ESP, L'Hospitalet de Llobregat, Avda. Gran via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. xcastellsague@iconcologia.net.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, CIBER-ESP, L'Hospitalet de Llobregat, Avda. Gran via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Paavonen, Jorma" sort="Paavonen, Jorma" uniqKey="Paavonen J" first="Jorma" last="Paavonen">Jorma Paavonen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynaecology, University of Helsinki, Helsinki, Finland. Jorma.Paavonen@hus.fi.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Department of Obstetrics and Gynaecology, University of Helsinki, Helsinki</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Jaisamrarn, Unnop" sort="Jaisamrarn, Unnop" uniqKey="Jaisamrarn U" first="Unnop" last="Jaisamrarn">Unnop Jaisamrarn</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynaecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. dr.unnop@yahoo.com.</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Department of Obstetrics and Gynaecology, Faculty of Medicine, Chulalongkorn University, Bangkok</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wheeler, Cosette M" sort="Wheeler, Cosette M" uniqKey="Wheeler C" first="Cosette M" last="Wheeler">Cosette M. Wheeler</name>
<affiliation wicri:level="1">
<nlm:affiliation>Departments of Pathology and Obstetrics and Gynecology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA. CWheeler@salud.unm.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Pathology and Obstetrics and Gynecology, University of New Mexico Health Sciences Center, Albuquerque, NM</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Skinner, S Rachel" sort="Skinner, S Rachel" uniqKey="Skinner S" first="S Rachel" last="Skinner">S Rachel Skinner</name>
<affiliation wicri:level="1">
<nlm:affiliation>Vaccines Trials Group, Telethon Institute for Child Health Research, Perth, WA and Sydney University Discipline of Paediatrics and Child Health, Children's Hospital Westmead, Sydney, NSW, Australia. rachels5@chw.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Vaccines Trials Group, Telethon Institute for Child Health Research, Perth, WA and Sydney University Discipline of Paediatrics and Child Health, Children's Hospital Westmead, Sydney, NSW</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lehtinen, Matti" sort="Lehtinen, Matti" uniqKey="Lehtinen M" first="Matti" last="Lehtinen">Matti Lehtinen</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Tampere, School of Public Health, Tampere, Finland. matti.lehtinen@uta.fi.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>University of Tampere, School of Public Health, Tampere</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Naud, Paulo" sort="Naud, Paulo" uniqKey="Naud P" first="Paulo" last="Naud">Paulo Naud</name>
<affiliation wicri:level="1">
<nlm:affiliation>Hospital de Clínicas de Porto Alegre, Department of Gynecology & Obstetrics Federal University of Rio Grande do Sul - UFRGS/HCPA, Porto Alegre, Brazil. cacontrol@hcpa.ufrgs.br.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Hospital de Clínicas de Porto Alegre, Department of Gynecology & Obstetrics Federal University of Rio Grande do Sul - UFRGS/HCPA, Porto Alegre</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Chow, Song Nan" sort="Chow, Song Nan" uniqKey="Chow S" first="Song-Nan" last="Chow">Song-Nan Chow</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, College of Medicine and the Hospital, National Taiwan University, Taipei, Taiwan. snchow@ntu.edu.tw.</nlm:affiliation>
<country xml:lang="fr">Taïwan</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, College of Medicine and the Hospital, National Taiwan University, Taipei</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Del Rosario Raymundo, Maria Rowena" sort="Del Rosario Raymundo, Maria Rowena" uniqKey="Del Rosario Raymundo M" first="Maria Rowena" last="Del Rosario-Raymundo">Maria Rowena Del Rosario-Raymundo</name>
<affiliation wicri:level="1">
<nlm:affiliation>San Pablo Colleges Medical Center, San Pablo City, Laguna, Philippines. runnymeadow@yahoo.com.</nlm:affiliation>
<country xml:lang="fr">Philippines</country>
<wicri:regionArea>San Pablo Colleges Medical Center, San Pablo City, Laguna</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Teixeira, Julio C" sort="Teixeira, Julio C" uniqKey="Teixeira J" first="Julio C" last="Teixeira">Julio C. Teixeira</name>
<affiliation wicri:level="1">
<nlm:affiliation>Departamento de Tocoginecologia da Unicamp, University of Campinas, Campinas, Sao Paulo, Brazil. juliotex@uol.com.br.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Departamento de Tocoginecologia da Unicamp, University of Campinas, Campinas, Sao Paulo</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Palmroth, Johanna" sort="Palmroth, Johanna" uniqKey="Palmroth J" first="Johanna" last="Palmroth">Johanna Palmroth</name>
<affiliation wicri:level="1">
<nlm:affiliation>Central Hospital of North Carelian, Department of Obstetrics and Gynecology, Joensuu, Finland. johanna.palmroth@dnainternet.net.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Central Hospital of North Carelian, Department of Obstetrics and Gynecology, Joensuu</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="De Carvalho, Newton S" sort="De Carvalho, Newton S" uniqKey="De Carvalho N" first="Newton S" last="De Carvalho">Newton S. De Carvalho</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Gynecology and Obstetrics, Federal University of Paraná, Infectious Diseases in Gynecology and Obstetrics Sector, Curitiba, Parana, Brazil. infectogin@ufpr.br.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Gynecology and Obstetrics, Federal University of Paraná, Infectious Diseases in Gynecology and Obstetrics Sector, Curitiba, Parana</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Germar, Maria Julieta V" sort="Germar, Maria Julieta V" uniqKey="Germar M" first="Maria Julieta V" last="Germar">Maria Julieta V. Germar</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynaecology, University of the Philippines College of Medicine, Philippines General Hospital, Manila, Philippines. jvgermar@yahoo.com.</nlm:affiliation>
<country xml:lang="fr">Philippines</country>
<wicri:regionArea>Department of Obstetrics and Gynaecology, University of the Philippines College of Medicine, Philippines General Hospital, Manila</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Peters, Klaus" sort="Peters, Klaus" uniqKey="Peters K" first="Klaus" last="Peters">Klaus Peters</name>
<affiliation wicri:level="1">
<nlm:affiliation>Facharzt für Frauenheilkunde und Geburtshilfe, Hamburg, Germany. klaus@dr-peters.net.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Facharzt für Frauenheilkunde und Geburtshilfe, Hamburg</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Garland, Suzanne M" sort="Garland, Suzanne M" uniqKey="Garland S" first="Suzanne M" last="Garland">Suzanne M. Garland</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville/Department of Microbiology, The Royal Children's Hospital, Parkville/Murdoch Children's Research Institute, Parkville/Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Australia. suzanne.garland@thewomens.org.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville/Department of Microbiology, The Royal Children's Hospital, Parkville/Murdoch Children's Research Institute, Parkville/Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Szarewski, Anne" sort="Szarewski, Anne" uniqKey="Szarewski A" first="Anne" last="Szarewski">Anne Szarewski</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Poppe, Willy A J" sort="Poppe, Willy A J" uniqKey="Poppe W" first="Willy A J" last="Poppe">Willy A J. Poppe</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Gynaecology, University Hospital KU Leuven Gasthuisberg, Leuven, Belgium. willy.Poppe@uz.kuleuven.ac.be.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Gynaecology, University Hospital KU Leuven Gasthuisberg, Leuven</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Romanowski, Barbara" sort="Romanowski, Barbara" uniqKey="Romanowski B" first="Barbara" last="Romanowski">Barbara Romanowski</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. broman@docromanowski.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Schwarz, Tino F" sort="Schwarz, Tino F" uniqKey="Schwarz T" first="Tino F" last="Schwarz">Tino F. Schwarz</name>
<affiliation wicri:level="1">
<nlm:affiliation>Central Laboratory and Vaccination Centre, Stiftung Juliusspital, Academic Teaching Hospital of the University of Wuerzburg, Wuerzburg, Germany. t.schwarz@juliusspital.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Central Laboratory and Vaccination Centre, Stiftung Juliusspital, Academic Teaching Hospital of the University of Wuerzburg, Wuerzburg</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Tjalma, Wiebren A A" sort="Tjalma, Wiebren A A" uniqKey="Tjalma W" first="Wiebren A A" last="Tjalma">Wiebren A A. Tjalma</name>
<affiliation wicri:level="1">
<nlm:affiliation>Multidisciplinary Breast Clinic and Gynaecological Oncology, Antwerp University Hospital, University of Antwerp, Antwerpen, Belgium. wiebren.tjalma@uza.be.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Multidisciplinary Breast Clinic and Gynaecological Oncology, Antwerp University Hospital, University of Antwerp, Antwerpen</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bosch, F Xavier" sort="Bosch, F Xavier" uniqKey="Bosch F" first="F Xavier" last="Bosch">F Xavier Bosch</name>
<affiliation wicri:level="1">
<nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, CIBER-ESP, L'Hospitalet de Llobregat, Avda. Gran via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. x.bosch@iconcologia.net.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, CIBER-ESP, L'Hospitalet de Llobregat, Avda. Gran via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bozonnat, Marie Cecile" sort="Bozonnat, Marie Cecile" uniqKey="Bozonnat M" first="Marie-Cecile" last="Bozonnat">Marie-Cecile Bozonnat</name>
<affiliation wicri:level="1">
<nlm:affiliation>4Clinics, Paris, France. mcbozonnat@4clinics.com.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>4Clinics, Paris</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Struyf, Frank" sort="Struyf, Frank" uniqKey="Struyf F" first="Frank" last="Struyf">Frank Struyf</name>
<affiliation wicri:level="1">
<nlm:affiliation>GlaxoSmithKline Vaccines, Wavre, Belgium. FRANK.STRUYF@GSK.COM.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>GlaxoSmithKline Vaccines, Wavre</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Dubin, Gary" sort="Dubin, Gary" uniqKey="Dubin G" first="Gary" last="Dubin">Gary Dubin</name>
<affiliation wicri:level="1">
<nlm:affiliation>GlaxoSmithKline Vaccines, King of Prussia, PA, USA. Gary.O.Dubin@gsk.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>GlaxoSmithKline Vaccines, King of Prussia, PA</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Rosillon, Dominique" sort="Rosillon, Dominique" uniqKey="Rosillon D" first="Dominique" last="Rosillon">Dominique Rosillon</name>
<affiliation wicri:level="1">
<nlm:affiliation>GlaxoSmithKline Vaccines, Wavre, Belgium. DOMINIQUE.X.ROSILLON@GSK.COM.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>GlaxoSmithKline Vaccines, Wavre</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Baril, Laurence" sort="Baril, Laurence" uniqKey="Baril L" first="Laurence" last="Baril">Laurence Baril</name>
<affiliation wicri:level="1">
<nlm:affiliation>GlaxoSmithKline Vaccines, Wavre, Belgium. LAURENCE.X.BARIL@GSK.COM.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>GlaxoSmithKline Vaccines, Wavre</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMC infectious diseases</title>
<idno type="eISSN">1471-2334</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged, 80 and over</term>
<term>Cervical Intraepithelial Neoplasia (epidemiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Papillomavirus Infections (epidemiology)</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Risk Factors</term>
<term>Sexual Behavior (statistics & numerical data)</term>
<term>Sexual Partners</term>
<term>Spain (epidemiology)</term>
<term>Time Factors</term>
<term>Uterine Cervical Neoplasms (epidemiology)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Comportement sexuel ()</term>
<term>Espagne (épidémiologie)</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Facteurs de risque</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Infections à papillomavirus (épidémiologie)</term>
<term>Jeune adulte</term>
<term>Néoplasie intraépithéliale cervicale (épidémiologie)</term>
<term>Partenaire sexuel</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tumeurs du col de l'utérus (épidémiologie)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Cervical Intraepithelial Neoplasia</term>
<term>Papillomavirus Infections</term>
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en">
<term>Sexual Behavior</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Espagne</term>
<term>Infections à papillomavirus</term>
<term>Néoplasie intraépithéliale cervicale</term>
<term>Tumeurs du col de l'utérus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Risk Factors</term>
<term>Sexual Partners</term>
<term>Time Factors</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Comportement sexuel</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Facteurs de risque</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Jeune adulte</term>
<term>Partenaire sexuel</term>
<term>Sujet âgé de 80 ans ou plus</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">More information is needed about time between sexual initiation and human papillomavirus (HPV) infection and development of cervical precancer.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">25927224</PMID>
<DateCreated>
<Year>2015</Year>
<Month>05</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>10</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised>
<Year>2016</Year>
<Month>12</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1471-2334</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>14</Volume>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>BMC infectious diseases</Title>
<ISOAbbreviation>BMC Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.</ArticleTitle>
<Pagination>
<MedlinePgn>551</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-014-0551-y</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">More information is needed about time between sexual initiation and human papillomavirus (HPV) infection and development of cervical precancer.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The objectives were to investigate the time between first sexual activity and detection of first cervical HPV infection or development of first cervical intraepithelial neoplasia (CIN), and associated factors in women from the double-blind, multinational, 4-year PATRICIA trial. PATRICIA enroled women aged 15-25 years with no more than 6 lifetime sexual partners. Women were randomized 1:1 to the HPV-16/18 AS04-adjuvanted vaccine or to control, but only women from the control arm who began sexual intercourse during the study or within 6 months before enrolment, and had no HPV infection detected before the recorded date of their first sexual intercourse, were included in the present analysis. The time between onset of sexual activity and detection of the first cervical HPV infection or development of the first CIN lesion was analyzed using Kaplan-Meier and univariate and multivariable Cox proportional-hazards models.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 9337 women were enroled in the control arm of PATRICIA of whom 982 fulfilled the required inclusion criteria for analysis. A cumulative total of 28%, 44%, and 62% of the subjects had HPV infection within 12, 24, and 48 months, respectively. The overall incidence rate was 27.08 per 100 person-years. The most common oncogenic types associated with 6-month persistent infection were HPV-16 (incidence rate: 2.74 per 100 person-years), HPV-51 (2.70), HPV-52 (1.66), HPV-66 (1.14), and HPV-18 (1.09). Increased infection risk was associated with more lifetime sexual partners, being single, Chlamydia trachomatis history, and duration of hormone use. CIN1+ and CIN2+ lesions were most commonly associated with HPV-16, with an overall incidence rate of 1.87 and 1.07 per 100 person-years, respectively. Previous cervical HPV infection was most strongly associated with CIN development.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">More than 25% of women were infected with HPV within 1 year of beginning sexual activity. Without underestimating the value of vaccination at older ages, our findings emphasize its importance before sexual initiation.</AbstractText>
<AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">clinicaltrials.gov: NCT00122681 .</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Castellsagué</LastName>
<ForeName>Xavier</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, CIBER-ESP, L'Hospitalet de Llobregat, Avda. Gran via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. xcastellsague@iconcologia.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Paavonen</LastName>
<ForeName>Jorma</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, University of Helsinki, Helsinki, Finland. Jorma.Paavonen@hus.fi.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jaisamrarn</LastName>
<ForeName>Unnop</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. dr.unnop@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wheeler</LastName>
<ForeName>Cosette M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Departments of Pathology and Obstetrics and Gynecology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA. CWheeler@salud.unm.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Skinner</LastName>
<ForeName>S Rachel</ForeName>
<Initials>SR</Initials>
<AffiliationInfo>
<Affiliation>Vaccines Trials Group, Telethon Institute for Child Health Research, Perth, WA and Sydney University Discipline of Paediatrics and Child Health, Children's Hospital Westmead, Sydney, NSW, Australia. rachels5@chw.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lehtinen</LastName>
<ForeName>Matti</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>University of Tampere, School of Public Health, Tampere, Finland. matti.lehtinen@uta.fi.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naud</LastName>
<ForeName>Paulo</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Hospital de Clínicas de Porto Alegre, Department of Gynecology & Obstetrics Federal University of Rio Grande do Sul - UFRGS/HCPA, Porto Alegre, Brazil. cacontrol@hcpa.ufrgs.br.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chow</LastName>
<ForeName>Song-Nan</ForeName>
<Initials>SN</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, College of Medicine and the Hospital, National Taiwan University, Taipei, Taiwan. snchow@ntu.edu.tw.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Del Rosario-Raymundo</LastName>
<ForeName>Maria Rowena</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>San Pablo Colleges Medical Center, San Pablo City, Laguna, Philippines. runnymeadow@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Teixeira</LastName>
<ForeName>Julio C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Tocoginecologia da Unicamp, University of Campinas, Campinas, Sao Paulo, Brazil. juliotex@uol.com.br.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Palmroth</LastName>
<ForeName>Johanna</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Central Hospital of North Carelian, Department of Obstetrics and Gynecology, Joensuu, Finland. johanna.palmroth@dnainternet.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Carvalho</LastName>
<ForeName>Newton S</ForeName>
<Initials>NS</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology and Obstetrics, Federal University of Paraná, Infectious Diseases in Gynecology and Obstetrics Sector, Curitiba, Parana, Brazil. infectogin@ufpr.br.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Germar</LastName>
<ForeName>Maria Julieta V</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, University of the Philippines College of Medicine, Philippines General Hospital, Manila, Philippines. jvgermar@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peters</LastName>
<ForeName>Klaus</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Facharzt für Frauenheilkunde und Geburtshilfe, Hamburg, Germany. klaus@dr-peters.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Garland</LastName>
<ForeName>Suzanne M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville/Department of Microbiology, The Royal Children's Hospital, Parkville/Murdoch Children's Research Institute, Parkville/Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Australia. suzanne.garland@thewomens.org.au.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Szarewski</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Poppe</LastName>
<ForeName>Willy A J</ForeName>
<Initials>WA</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology, University Hospital KU Leuven Gasthuisberg, Leuven, Belgium. willy.Poppe@uz.kuleuven.ac.be.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Romanowski</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. broman@docromanowski.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schwarz</LastName>
<ForeName>Tino F</ForeName>
<Initials>TF</Initials>
<AffiliationInfo>
<Affiliation>Central Laboratory and Vaccination Centre, Stiftung Juliusspital, Academic Teaching Hospital of the University of Wuerzburg, Wuerzburg, Germany. t.schwarz@juliusspital.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tjalma</LastName>
<ForeName>Wiebren A A</ForeName>
<Initials>WA</Initials>
<AffiliationInfo>
<Affiliation>Multidisciplinary Breast Clinic and Gynaecological Oncology, Antwerp University Hospital, University of Antwerp, Antwerpen, Belgium. wiebren.tjalma@uza.be.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bosch</LastName>
<ForeName>F Xavier</ForeName>
<Initials>FX</Initials>
<AffiliationInfo>
<Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, CIBER-ESP, L'Hospitalet de Llobregat, Avda. Gran via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. x.bosch@iconcologia.net.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Network on Cooperative Cancer Research, RTICC, Catalonia, Spain. x.bosch@iconcologia.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bozonnat</LastName>
<ForeName>Marie-Cecile</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>4Clinics, Paris, France. mcbozonnat@4clinics.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Struyf</LastName>
<ForeName>Frank</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>GlaxoSmithKline Vaccines, Wavre, Belgium. FRANK.STRUYF@GSK.COM.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dubin</LastName>
<ForeName>Gary</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>GlaxoSmithKline Vaccines, King of Prussia, PA, USA. Gary.O.Dubin@gsk.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rosillon</LastName>
<ForeName>Dominique</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>GlaxoSmithKline Vaccines, Wavre, Belgium. DOMINIQUE.X.ROSILLON@GSK.COM.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baril</LastName>
<ForeName>Laurence</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>GlaxoSmithKline Vaccines, Wavre, Belgium. LAURENCE.X.BARIL@GSK.COM.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>HPV PATRICIA Study Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT00122681</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Infect Dis</MedlineTA>
<NlmUniqueID>100968551</NlmUniqueID>
<ISSNLinking>1471-2334</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2001 Jan 1;183(1):8-15</RefSource>
<PMID Version="1">11087198</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(11):e79260</RefSource>
<PMID Version="1">24260180</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2001 Jun 9;357(9271):1831-6</RefSource>
<PMID Version="1">11410191</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2001 Dec 15;184(12):1508-17</RefSource>
<PMID Version="1">11740725</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2002 Feb 1;185(3):324-31</RefSource>
<PMID Version="1">11807714</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BJOG. 2002 Jan;109(1):96-8</RefSource>
<PMID Version="1">11845815</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2002 Oct 1;101(4):371-4</RefSource>
<PMID Version="1">12209962</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2003 Feb 1;157(3):218-26</RefSource>
<PMID Version="1">12543621</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 1994 Feb;169(2):235-40</RefSource>
<PMID Version="1">8106758</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pathol. 1999 Sep;189(1):12-9</RefSource>
<PMID Version="1">10451482</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2005 Jan 15;191(2):182-92</RefSource>
<PMID Version="1">15609227</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2005 Aug 10;116(1):110-5</RefSource>
<PMID Version="1">15756673</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2005 Oct 1;192(7):1158-65</RefSource>
<PMID Version="1">16136457</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2006 Mar 15;118(6):1481-95</RefSource>
<PMID Version="1">16206285</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J STD AIDS. 2006 Aug;17(8):517-21</RefSource>
<PMID Version="1">16925896</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Microbiol. 2006 Sep;44(9):3292-8</RefSource>
<PMID Version="1">16954263</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2006 Nov 1;194(9):1291-9</RefSource>
<PMID Version="1">17041856</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2007 Feb 15;120(4):885-91</RefSource>
<PMID Version="1">17131323</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sex Transm Dis. 2007 Jul;34(7):494-502</RefSource>
<PMID Version="1">17237737</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2007 Jun 30;369(9580):2161-70</RefSource>
<PMID Version="1">17602732</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2008 Jul 15;168(2):123-37</RefSource>
<PMID Version="1">18483125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 2008 Aug 19;26 Suppl 10:K1-16</RefSource>
<PMID Version="1">18847553</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1060-9</RefSource>
<PMID Version="1">19336546</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2009 Jul 25;374(9686):301-14</RefSource>
<PMID Version="1">19586656</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2010 Dec 15;202(12):1789-99</RefSource>
<PMID Version="1">21067372</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gynecol Oncol. 2012 Dec;127(3):440-50</RefSource>
<PMID Version="1">22940493</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):101-6</RefSource>
<PMID Version="1">11219765</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018290" MajorTopicYN="N">Cervical Intraepithelial Neoplasia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D030361" MajorTopicYN="N">Papillomavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012725" MajorTopicYN="N">Sexual Behavior</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012747" MajorTopicYN="N">Sexual Partners</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4251672</OtherID>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Denham</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Garland</LastName>
<ForeName>S M</ForeName>
<Initials>SM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mindel</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Skinner</LastName>
<ForeName>S R</ForeName>
<Initials>SR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>De Sutter</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Poppe</LastName>
<ForeName>W A J</ForeName>
<Initials>WA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tjalma</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>De Carvalho</LastName>
<ForeName>N S</ForeName>
<Initials>NS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Naud</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Teixeira</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Aoki</LastName>
<ForeName>F Y</ForeName>
<Initials>FY</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diaz-Mitoma</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dionne</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ferguson</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Miller</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Papp</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ramjattan</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Romanowski</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Orr</LastName>
<ForeName>P H</ForeName>
<Initials>PH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Somani</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Apter</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Karppa</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kudjoi</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kyha-Österlund</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lehtinen</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lönnberg</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lunnas</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Paavonen</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Palmroth</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Petaja</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vilkki</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gent</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Grubert</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Höpker</LastName>
<ForeName>W D</ForeName>
<Initials>WD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Peters</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schulze</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schwarz</LastName>
<ForeName>T F</ForeName>
<Initials>TF</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Salmerón</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Crisostomo</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Del Rosario-Raymundo</LastName>
<ForeName>M R</ForeName>
<Initials>MR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Raymundo</LastName>
<ForeName>J E</ForeName>
<Initials>JE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Germar</LastName>
<ForeName>M J</ForeName>
<Initials>MJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Limson</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Remollino</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Villanueva</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Villanueva</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zamora</LastName>
<ForeName>J D</ForeName>
<Initials>JD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bajo-Arenas</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bayas</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Campins</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Castellsagué</LastName>
<ForeName>X</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Castro</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Centeno</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>de la Pinta</LastName>
<ForeName>M L Rodríguez</ForeName>
<Initials>ML</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Torné</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vidart</LastName>
<ForeName>J A</ForeName>
<Initials>JA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chow</LastName>
<ForeName>S N</ForeName>
<Initials>SN</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>M H</ForeName>
<Initials>MH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Angsuwathana</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jaisamrarn</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cruickshank</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hakim</LastName>
<ForeName>E A</ForeName>
<Initials>EA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kitchener</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lewis</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Szarewski</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ackerman</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Caldwell</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chambers</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chatterjee</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>DeMars</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Downs</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ferris</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fine</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hedrick</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Huh</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Klein</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lalezari</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Luber</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Martens</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Peterson</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rosen</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Seidman</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sperling</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sperling</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Stager</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Stapleton</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Swenson</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Thoming</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Twiggs</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Waldbaum</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wheeler</LastName>
<ForeName>C M</ForeName>
<Initials>CM</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2014</Year>
<Month>04</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>5</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>10</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25927224</ArticleId>
<ArticleId IdType="doi">10.1186/s12879-014-0551-y</ArticleId>
<ArticleId IdType="pii">10.1186/s12879-014-0551-y</ArticleId>
<ArticleId IdType="pmc">PMC4251672</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003300 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003300 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:25927224
   |texte=   Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:25927224" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024